PL321538A1 - Additional protein of a human interleukin-1 receptor - Google Patents

Additional protein of a human interleukin-1 receptor

Info

Publication number
PL321538A1
PL321538A1 PL96321538A PL32153896A PL321538A1 PL 321538 A1 PL321538 A1 PL 321538A1 PL 96321538 A PL96321538 A PL 96321538A PL 32153896 A PL32153896 A PL 32153896A PL 321538 A1 PL321538 A1 PL 321538A1
Authority
PL
Poland
Prior art keywords
receptor
human interleukin
additional protein
protein
additional
Prior art date
Application number
PL96321538A
Inventor
Richard Anthony Chizzonite
Grace Wong Ju
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL321538A1 publication Critical patent/PL321538A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL96321538A 1995-01-23 1996-01-17 Additional protein of a human interleukin-1 receptor PL321538A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37626895A 1995-01-23 1995-01-23
PCT/EP1996/000181 WO1996023067A1 (en) 1995-01-23 1996-01-17 Human interleukin-1 receptor accessory protein

Publications (1)

Publication Number Publication Date
PL321538A1 true PL321538A1 (en) 1997-12-08

Family

ID=23484321

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96321538A PL321538A1 (en) 1995-01-23 1996-01-17 Additional protein of a human interleukin-1 receptor

Country Status (19)

Country Link
EP (1) EP0808365A1 (en)
JP (1) JPH10512453A (en)
AR (1) AR003919A1 (en)
AU (1) AU4537096A (en)
BR (1) BR9606837A (en)
CA (1) CA2210724A1 (en)
CO (1) CO4480033A1 (en)
CZ (1) CZ208197A3 (en)
EA (1) EA199700265A1 (en)
FI (1) FI973089A (en)
HU (1) HUP9702458A2 (en)
IL (1) IL116796A0 (en)
MX (1) MX9705501A (en)
NO (1) NO973404D0 (en)
PE (1) PE64396A1 (en)
PL (1) PL321538A1 (en)
TR (1) TR199700652T1 (en)
WO (1) WO1996023067A1 (en)
ZA (1) ZA96333B (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974682B1 (en) 1996-08-26 2005-12-13 Human Genome Sciences, Inc. Soluble interleukin-1 receptor accessory molecule
AU7011696A (en) * 1996-08-26 1998-03-19 Human Genome Sciences, Inc. Soluble interleukin-1 receptor accessory molecule
EP2002846B1 (en) 1996-12-06 2017-01-25 Amgen Inc. Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
AU741330B2 (en) * 1997-04-30 2001-11-29 F. Hoffmann-La Roche Ag Rat ST38.2 chemokine
US6280955B1 (en) * 1997-12-16 2001-08-28 Tularik Inc. Interleukin-1 receptor accessory proteins, nucleic acids and methods
WO1999032626A1 (en) 1997-12-23 1999-07-01 Immunex Corporation Sigirr dna and polypeptides
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
AU2002253842A1 (en) 2000-10-31 2002-08-28 Immunex Corporation Il-1 receptor accessory protein
GB2375604A (en) * 2001-05-18 2002-11-20 Warner Lambert Co Methods for screening using interleukin soluble trimolecular complex
NZ530765A (en) 2001-06-26 2006-11-30 Amgen Fremont Inc Antibodies that bind OPGL and compositions and methods for the treatment of bone diseases
KR100453877B1 (en) 2001-07-26 2004-10-20 메덱스젠 주식회사 METHOD OF MANUFACTURING Ig-FUSION PROTEINS BY CONCATAMERIZATION, TNFR/Fc FUSION PROTEINS MANUFACTURED BY THE METHOD, DNA CODING THE PROTEINS, VECTORS INCLUDING THE DNA, AND CELLS TRANSFORMED BY THE VECTOR
AU2002324625B2 (en) * 2001-08-07 2008-05-08 Immunex Corporation Interleukin-1 receptors in the treatment of diseases
MXPA05002514A (en) 2002-09-06 2005-05-27 Amgen Inc Therapeutic human anti-il-1r1 monoclonal antibody.
DK1729810T3 (en) 2004-04-02 2018-12-03 Swedish Orphan Biovitrum Ab Publ PROCEDURE FOR REDUCING AGGREGATION OF IL-1RA
US8618054B2 (en) 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
CA2607113C (en) * 2004-05-05 2013-11-12 Valorisation-Recherche, Societe En Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
JP2008542685A (en) * 2005-05-05 2008-11-27 ヴァロリザーシヨン・アッシュエスジ，ソシエテ・アン・コマンディット Cytokine receptor modifier and use thereof
PE20070684A1 (en) 2005-11-14 2007-08-06 Amgen Inc RANKL-PTH / PTHrP ANTIBODY CHEMERICAL MOLECULES
US20110044894A1 (en) 2008-03-26 2011-02-24 Cellerant Therapeutics, Inc. Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof
EP2196476A1 (en) 2008-12-10 2010-06-16 Novartis Ag Antibody formulation
GB2472856B (en) * 2009-08-21 2012-07-11 Cantargia Ab IL1-RAP modulators and uses thereof
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
DK3020730T3 (en) 2011-01-19 2019-04-15 Cantargia Ab ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATMENT OF SOLID TUMORS
AU2011358564B9 (en) 2011-02-09 2017-07-13 Natera, Inc Methods for non-invasive prenatal ploidy calling
US20150030586A1 (en) * 2011-06-21 2015-01-29 Sarah Ellen Warren Compositions and methods for the therapy and diagnosis of cancer
US8841418B2 (en) 2011-07-01 2014-09-23 Cellerant Therapeutics, Inc. Antibodies that specifically bind to TIM3
GB201403875D0 (en) 2014-03-05 2014-04-16 Cantargia Ab Novel antibodies and uses thereof
GB201413913D0 (en) 2014-08-06 2014-09-17 Cantargia Ab Novel antibodies and uses thereof
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
CA2990305A1 (en) 2015-06-26 2016-12-29 Mab Discovery Gmbh Monoclonal anti-il-1racp antibodies
EP3241845A1 (en) 2016-05-06 2017-11-08 MAB Discovery GmbH Humanized anti-il-1r3 antibodies
US10041044B2 (en) 2016-07-29 2018-08-07 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
EP3401332A1 (en) 2017-05-08 2018-11-14 MAB Discovery GmbH Anti-il-1r3 antibodies for use in inflammatory conditions
CN110945136A (en) 2017-06-20 2020-03-31 威斯康星州立大学医学院 Assessment of risk of transplantation complications using total cell-free DNA
TW202021618A (en) 2018-08-17 2020-06-16 美商２３與我有限公司 Anti-il1rap antibodies and methods of use thereof
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
WO2021236962A1 (en) 2020-05-20 2021-11-25 The Medical College Of Wisconsin, Inc. Compositions and methods for inhibiting cytokine-release syndrome
WO2022247937A1 (en) * 2021-05-28 2022-12-01 Biocytogen Jiangsu Co., Ltd. Genetically modified non-human animal with human or chimeric il1rap

Also Published As

Publication number Publication date
BR9606837A (en) 1998-05-26
NO973404L (en) 1997-07-23
IL116796A0 (en) 1996-05-14
FI973089A0 (en) 1997-07-22
MX9705501A (en) 1997-10-31
EP0808365A1 (en) 1997-11-26
JPH10512453A (en) 1998-12-02
EA199700265A1 (en) 1998-04-30
FI973089A (en) 1997-07-22
CZ208197A3 (en) 1997-11-12
HUP9702458A2 (en) 1998-04-28
AR003919A1 (en) 1998-09-30
ZA96333B (en) 1996-07-23
NO973404D0 (en) 1997-07-23
TR199700652T1 (en) 1998-02-21
WO1996023067A1 (en) 1996-08-01
CA2210724A1 (en) 1996-08-01
PE64396A1 (en) 1997-01-28
AU4537096A (en) 1996-08-14
CO4480033A1 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
PL321538A1 (en) Additional protein of a human interleukin-1 receptor
EP0828751A4 (en) Human neuropeptide receptor
AU2236895A (en) Human g-protein coupled receptors
AU2766395A (en) Human g-protein receptor hgber32
IL116924A0 (en) Preparation of n-aryl- and n-hetarylhydroxylamines
AU2662695A (en) Human g-protein receptor hpraj70
EP0815133A4 (en) Human stat4
AU6035398A (en) Human c5a-like receptor
AU2663495A (en) Human g-protein receptor hcegh45
AU4459196A (en) Sustained-release preparation and use
AU8019494A (en) Human endothelin-bombesin receptor
EP0812329A4 (en) Human g-protein coupled receptor
EP0833846A4 (en) Human g-protein coupled receptor (hetgq23)
ZA968873B (en) Isomerisation of equillin
NZ307236A (en) Preparation of streptogramins
IL117786A (en) Preparation of alpha-bisoximes
AU6779798A (en) Novel human cytokine/steroid receptor protein
AU2699695A (en) Human amine receptor
AU1270099A (en) Human progesterone receptor complex p23-like protein
AU2699795A (en) Human g-protein receptor hibef51
AU4189196A (en) Expression inhibitor against human interleukin-6 receptor
GB9511109D0 (en) Receptor proteins
GB9403285D0 (en) Human glutamate receptor protein
GB9415532D0 (en) Human glutamate receptor protein
GB9508618D0 (en) Therapeutic protein